Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, what assessment her Department has made of the potential impact of the unavailability of Act-O-Vial hydrocortisone in the UK on patient safety.

I refer the Hon. Member to the answers provided on 22 April in response to Question 126862 and on 25 June in response to Question 9822.